44 results
8-K
EX-10.1
qpwbm xy9hjm4a
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.24.1
15lvho
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.5
woh 6qh37b8c
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.2
z9bsqt6
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.1
aix1jmp5o27gdlxk0
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
424B3
3qp1lxbxkij7qc
22 Sep 23
Prospectus supplement
4:08pm
425
EX-10.2
dsd6v
22 Sep 23
Business combination disclosure
12:55pm
8-K
EX-10.2
inty7y 5838k11
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
424B3
u9o0yxotecwef7e3fu9
21 Sep 23
Prospectus supplement
7:31pm
425
EX-10.1
grkm0ohhm5elxj0ez
19 Sep 23
Business combination disclosure
3:52pm
8-K
EX-10.1
fv0swbocsj 104izid
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm